Hemophilia Market Analysis by Type (Type A, B, C,), by Treatment (Prophylaxis, On-Demand), by Therapy (Gene, Replacement, Immune Tolerance Induction (ITI) Therapy), and by Region - Forecast to 2029

Request Sample Page

The global hemophilia market size is estimated to be USD 12.6 billion in 2021 and is expected to witness a CAGR of 5.79% during the forecast period. Rising adoption of prophylaxis treatment is a key driver for the growth of the global hemophilia market. Additionally, increasing cases of hemophilia in new-born, growing investment in R&D activities for new product development, and rise in favourable initiatives taken by the government are some of the other drivers propelling the market growth. Nevertheless, lack of knowledge regarding hemophilia among developing economies and low acceptance rates of advanced products are expected to restrain the global market growth.

Global Hemophilia Market Size (USD Billion), 2021-2029

Source: Erevna Healthcare

By Type

Based on type, the market is divided into hemophilia A, B, C, and others. The hemophilia A segment accounted for the major revenue in 2021 and is projected to maintain its dominance over the forecast period. The growth is due to the fact that this type of segment is the most commonly found type of haemophilia worldwide. The hemophilia B segment is anticipated to grow at a lucrative CAGR during the forecast period, due to the increase in number of products being launched by key pharmaceutical and biotechnology companies for the haemophilia B type segment.

By Treatment

Based on treatment, the market is categorized into prophylaxis and on-demand. The on-demand segment accounted for the major revenue in 2021 and is projected to maintain its dominance over the forecast period. The growth is due to the increasing application of on-demand treatment as it offers various benefits such as increasing productivity worldwide. The prophylaxis segment is anticipated to grow at a lucrative CAGR during the forecast period, due to the increase in the application of this segment in patients who are suffering from severe hemophilia.

By Therapy

Based on therapy, the market is categorized into gene therapy, replacement therapy, and immune tolerance induction (ITI) therapy. The replacement therapy segment accounted for the highest revenue in 2021 and is projected to maintain its dominance over the forecast period. The growth for this segment is because it is considered as the standard therapy that is used for replacing the missing clotting factor among different patients worldwide. The gene therapy segment is anticipated to grow at a significant CAGR during the forecast period, due to the application of this segment in identifying the malfunctioning DNA and reinstating it with the functional ones.

Regional Insights

In 2021, North America accounted for the largest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the growing consciousness about the benefits of early detection of hemophilia, favourable reimbursement policies by the government, and increasing preference for prophylaxis treatment in this region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the growing number of hemophilic patients, introduction of new drugs in the market, and increasing awareness regarding technologically advanced products in this region.

Competitor Insights

Some of the key players in the hemophilia market Novo Nordisk A/S (Denmark); Shire plc (U.S.); Chugai Pharmaceutical Co. Ltd. (Japan); Bayer AG (Germany); Pfizer, Inc. (U.S.); CSL Behring (U.S.); BioMarin (U.S.); Octopharma AG (Switzerland); Genzyme Corporation (U.S.); and Spark Therapeutics, Inc. (U.S.). The leading players operating in the hemophilia industry are adopting various strategies including R&D investments, adoption of advanced techniques, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The hemophilia market report is categorized into the following segments and subsegments:

Hemophilia Market, By Type (Revenue, USD Billion, 2021 – 2029)

  • Hemophilia A
  • Hemophilia B
  • Hemophilia C
  • Others

Hemophilia Market, By Treatment (Revenue, USD Billion, 2021 – 2029)

  • Prophylaxis
  • On-demand

Hemophilia Market, By Therapy (Revenue, USD Billion, 2021 – 2029)

  • Gene therapy
  • Replacement therapy
  • ITI therapy

Hemophilia Market, By Region (Revenue, USD Billion, 2021 – 2029)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Hemophilia Market Report:

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 15 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Table of Contents: Hemophilia  Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction: Hemophilia
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis: Hemophilia Market  
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Type
    1. Type A
      1. Type A Market Forecast, 2021-2029 (USD Million)
    2. Type B
      1. Type B Market Forecast, 2021-2029 (USD Million)
    3. Type C
      1. Type C Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Treatment
    1. Prophylaxis
      1. Prophylaxis Market Forecast, 2021-2029 (USD Million)
    2. On-demand
      1. On-demand Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Therapy
    1. Gene therapy
      1. Gene therapy Market Forecast, 2021-2029 (USD Million)
    2. Replacement therapy
      1. Replacement therapy Market Forecast, 2021-2029 (USD Million)
    3. ITI therapy
      1. ITI therapy Market Forecast, 2021-2029 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North America Hemophilia Market  
    1. North America Hemophilia Market
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
        3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
      2. S. Hemophilia Market
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
          3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
        2. Canada Hemophilia Market
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
            3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
  1. Europe Hemophilia Market  
    1. Europe Hemophilia Market
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
        3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
      2. Germany Hemophilia Market
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
          3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
        2. UK Hemophilia Market
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
            3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
          2. France Hemophilia Market
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Type, 2021-2029 (USD Million)
              2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
              3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
            2. Spain Hemophilia Market
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
                3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
              2. Italy Hemophilia Market
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
                  3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
                2. Rest of Europe Hemophilia Market
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
                    3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
  1. Asia Pacific Hemophilia Market  
    1. Asia Pacific Hemophilia Market
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
        3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
      2. Japan Hemophilia Market
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
          3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
        2. China Hemophilia Market
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
            3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
          2. India Hemophilia Market
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Type, 2021-2029 (USD Million)
              2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
              3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
            2. South Korea Hemophilia Market
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
                3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
              2. Australia Hemophilia Market
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
                  3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
                2. Rest of Asia Pacific Hemophilia Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
                    3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
  1. Latin America Hemophilia Market  
    1. Latin America Hemophilia Market
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
        3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
      2. Brazil Hemophilia Market
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
          3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
        2. Mexico Hemophilia Market
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
            3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
          2. Argentina Hemophilia Market
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Type, 2021-2029 (USD Million)
              2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
              3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
            2. Rest of Latin America Hemophilia Market
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
                3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
  1. MEA Hemophilia Market  
    1. MEA Hemophilia Market
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
        3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
      2. GCC Hemophilia Market
        1. GCC Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
          3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
        2. South Africa Hemophilia Market
          1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
            3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
          2. Rest of MEA Hemophilia Market
            1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Type, 2021-2029 (USD Million)
              2. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
              3. Market Size and Forecast by Therapy, 2021-2029 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2021 & 2029
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. Baxter International, Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Treatment Benchmarking
      5. Recent Developments
    2. Baxter International, Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Treatment Benchmarking
      5. Recent Developments
    3. Grifols SA (Spain)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Treatment Benchmarking
      5. Recent Developments
    4. CSL Ltd. (Australia)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Treatment Benchmarking
      5. Recent Developments
    5. Octapharma AG (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Treatment Benchmarking
      5. Recent Developments
    6. Novo Nordisk (Denmark)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Treatment Benchmarking
      5. Recent Developments
    7. Kedrion (Italy)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Treatment Benchmarking
      5. Recent Developments
    8. Pfizer, Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Treatment Benchmarking
      5. Recent Developments
    9. Bayer AG (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Treatment Benchmarking
      5. Recent Developments
    10. Biogen Idec, Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Treatment Benchmarking
      5. Recent Developments
    11. Hospira, Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    16. Others Prominent Players

Conclusion & Recommendations

Select License Type

Buy Now

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports

Trending Reports